Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
Clinical trial NCT01222975 · COMPLETED
Trial details
- NCT number
- NCT01222975
- Sponsor
- Ranbaxy Laboratories Limited
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2004-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.